#USA #New York #Class Action #Securities Fraud #Capricor Therapeutics

Opportunity for Capricor Investors to Lead a Securities Fraud Lawsuit

Capricor Therapeutics, Inc. (NASDAQ: CAPR) has become a focal point for investors who purchased securities in the company between October 9, 2024, and July 10, 2025. The Rosen Law Firm, a prominent global investor rights law firm, has issued a notice reminding those affected by potential securities fraud that time is running out to take action.

Key Deadline

On September 15, 2025, the Rosen Law Firm will mark a critical date for investors. Those who have incurred losses exceeding $100,000 during the Class Period may have a chance to serve as lead plaintiffs in a lawsuit against Capricor. This position is crucial, as it allows individuals to represent other investors and guide the direction of the litigation.

No Upfront Fees

For those concerned about the costs associated with joining the lawsuit, the Rosen Law Firm operates on a contingency fee basis. This means that investors can join the class action without any upfront payment or out-of-pocket expenses, making it accessible for those who may be hesitant due to financial constraints.

Legal Landscape

The allegations in the lawsuit assert that Capricor misled investors by providing overly optimistic information regarding its lead product, deramiocel, a cell therapy aimed at treating cardiomyopathy linked to Duchenne muscular dystrophy (DMD). Throughout the aforementioned Class Period, Capricor allegedly communicated its ability to secure a Biologics License Application (BLA) from the U.S. Food and Drug Administration (FDA) while simultaneously concealing critical adverse facts from investors regarding safety and efficacy data derived from the company’s trials.

Damages Incurred

As the legal proceedings unfold and details of the company's practices come to light, investors are encouraged to consider their standings within the context of the law. The complaint claims that misinformation provided by Capricor led to artificially inflated stock prices, causing financial damage to many shareholders when the truth emerged and triggered a significant drop in the company's stock value.

How to Join the Class Action

Investors interested in joining the class action are advised to visit Rosen Legal or contact Phillip Kim, Esq. at 866-767-3653 for further details. While no class has currently been certified, affected individuals can take proactive steps to secure their interests and protect their rights as shareholders.

The Importance of Experienced Counsel

The Rosen Law Firm emphasizes the importance of choosing qualified legal representation with a successful track record in securities class actions. Many firms that circulate notices may lack the necessary experience, which underscores the value of a specialized firm that can navigate the complexities of securities litigation actively. The expertise of The Rosen Law Firm is highlighted by their history of significant recoveries for investors, including a notable $438 million secured in 2019 alone.

Conclusion

For Capricor investors with significant losses, the approaching deadlines signal a crucial opportunity to seek justice and potentially recover damages through a collective lawsuit. Ensuring representation by an established firm like The Rosen Law Firm could make a significant difference in the outcome of this case. Investors are advised to act promptly in order not to miss this vital opportunity.

Stay updated on the proceedings via The Rosen Law Firm’s social media channels on LinkedIn, Twitter, and Facebook.